Delivery Order SPE2DR25D2104-SPE2DR26F3STD
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,651.43 to AmerisourceBergen Drug Corp for the supply of Quelipita 60 mg tablets (30-count packages) on September 5, 2025, with an ultimate completion date of September 8, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract is being performed at...
- The Defense Logistics Agency awarded a $1,738.19 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Quelipita 60 mg tablets (30-count). This firm fixed-price, non-set-aside contract is scheduled for completion by September 17, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively selected to fulfill this medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Queliptá 60 mg tablets (30-count packaging) with a firm fixed price ceiling value of $1,358.64. This non-competed delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at approximately $1 billion through December 2026. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $3,843.56 to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Quelipat 60 mg tablets (30-count packaging). This non-set-aside, competitively awarded contract utilizes firm fixed pricing and requires ultimate completion by November 21, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents one of...
- The Defense Logistics Agency awarded a $4,027.02 delivery order to AmerisourceBergen Drug Corp for Quilpta 60 mg tablets (30-count package) on August 1, 2025, with an ultimate completion date of August 4, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $64,765.81 on September 8, 2025, for the supply of Queliptta 60 mg tablets (30-count) with an ultimate completion date of October 3, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,226.74 for 30 tablets of Quelipra 60 mg on December 15, 2025, with completion scheduled for December 16, 2025. This firm fixed-price contract represents a non-competitive delivery order executed under the company's existing indefinite delivery vehicle with DLA. The award is being performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, where the company operates as a major...
- The Defense Logistics Agency awarded a $26,473.25 delivery order to AmerisourceBergen Drug Corp for Qualipta 60 mg tablets (30-count units) on September 8, 2025, with an ultimate completion date of September 9, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $54,878.67 to AmerisourceBergen Drug Corp for the supply of Qualipita 60 mg tablets (30-count packages) on October 30, 2025, with completion expected by October 31, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Qualipita 60 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $6,180.83 and an ultimate completion date of January 6, 2026. This non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3STDDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11.3 thousand to AmerisourceBergen Drug Corp for the supply of Quelipita 60 mg tablets (30-count packages) on January 5, 2026, with an ultimate completion date of January 6, 2026. This firm fixed-price delivery order represents a competitively awarded non-set-aside contract and is being performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order under its large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.999 billion through December 2026. As a critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products to support military and veteran healthcare systems worldwide. The SPE2DX contract serves as a global pharmaceutical support vehicle enabling the company to deliver specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. This delivery order exemplifies the company's role in the DLA's medical supply chain and its demonstrated capability to meet federal procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.3k | 1/4/26 |